Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03603964
Title Guadecitabine Extension Study
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Astex Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ESP | CAN | AUT

Facility Status City State Zip Country Details
Roswell Park Buffalo New York 14263 United States Details
Duke Cancer Center Durham North Carolina 27705 United States Details
Ohio State University Columbus Ohio 43210 United States Details
Temple University Philadelphia Pennsylvania 19111 United States Details
Center for Blood Cancers Nashville Tennessee 37203 United States Details
Medizinische Universität Graz Graz Styria Austria Details
The Ottawa Hospital - General Ottawa Ontario K1H 8L6 Canada Details
Princess Margaret Cancer Center Toronto Ontario M5G 2M9 Canada Details
Rigshospitalet-Copenhagen University Hospital Copenhagen Denmark Details
Azienda Ospedaliera SS. Antonio E. Biagio E. Cesare Arrigo di Alessandria Alessandria Italy Details
Azienda Ospedaliera Universitaria San Martino Genova Italy Details
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano Italy Details
Azienda Ospedaliero Universitaria S. Maria della Misericordia di Udine Udine Italy Details
Tokai University Hospital Isehara-shi 259-1193 Japan Details
Japanese Red Cross Kyoto Daini Hospital Kyoto-shi 602-8026 Japan Details
Saga University Hospital Saga-shi 849-8501 Japan Details
Severance Hospital, Yonsei University Health System Seoul 03722 Korea, Republic of Details
Ulsan University Hospital Ulsan 44033 Korea, Republic of Details
Hospital Universitario 12 de Octubre Madrid Spain Details
Mackay Memorial Hospital Taipei Taiwan Details
National Taiwan University Hospital Taipei Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field